<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">918</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2020-1-2-3-10-13</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Russian Pharmaceutical Market in 2019</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kalinina</surname><given-names>Nadezhda</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><pub-date date-type="epub" iso-8601-date="2020-12-01" publication-format="electronic"><day>01</day><month>12</month><year>2020</year></pub-date><issue>1-3</issue><fpage>10</fpage><lpage>13</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><abstract>In 2019, the government segment and procurement of expensive drugs became the growth driver of the pharmaceutical market for the first time due to the implementation of the facility mainly related to the organization of cancer care within the framework of the National Healthcare Project. Through this process, the slowdown in growth rates of the Russian pharmaceutical market unexpectedly discontinued in many respects.</abstract><kwd-group xml:lang="en"><kwd>Russian pharmaceutical market</kwd><kwd>retail sector</kwd><kwd>pharmaceutical benefits</kwd><kwd>high cost ICD diseases</kwd><kwd>hospital procurement</kwd><kwd>regional subsidized drug list</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>российский фармацевтический рынок</kwd><kwd>розничный сектор</kwd><kwd>лекарственное обеспечение</kwd><kwd>ВЗН</kwd><kwd>госпитальные закупки</kwd><kwd>региональная льгота</kwd></kwd-group></article-meta></front><body></body><back/></article>
